Search - tctmd.com

Displaying 301 - 320 of 370

Sort: Relevancy | Date

Presentation CHIP Washington DC 2017

Hybrid CTO Case Review: Forwards, Backwards, True, Sub, or All of the Above?

Presenter: Farouc Jaffer

March 16, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Daily News

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

L.A. McKeown

November 10, 2016

News Conference News TCT 2016

Novel SES Fails to Match Xience EES for Chronic Total Occlusions

Yael L. Maxwell

November 08, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Conference News TCT 2016

硬 CTO 斑块的新软化方法可以降低手术难度

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Daily News

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

Michael O'Riordan

October 18, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Michael O'Riordan

July 27, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Daily News

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

Leah Lawrence

May 25, 2016

News Daily News

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Leah Lawrence

May 25, 2016

Advertisement

Hybrid CTO Case Review: Forwards, Backwards, True, Sub, or All of the Above?

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

Novel SES Fails to Match Xience EES for Chronic Total Occlusions

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

硬 CTO 斑块的新软化方法可以降低手术难度

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content